StockNews.com Initiates Coverage on OncoCyte (NASDAQ:OCX)

StockNews.com initiated coverage on shares of OncoCyte (NASDAQ:OCX – Free Report) in a report released on Monday morning. The firm issued a sell rating on the stock. OCX has been the topic of several other research reports. Benchmark dropped their price objective on OncoCyte from $9.00 to $5.00 and set a speculative buy rating on […]

Leave a Reply

Your email address will not be published.

Previous post StockNews.com Initiates Coverage on ContraFect (NASDAQ:CFRX)
Next post Zovio (NYSE:ZVO) Earns Hold Rating from Analysts at StockNews.com